pneumonia
Conditions
Interventions
Experimental group:Children with pneumonia with feipishire syndrome, in addition to simple Western medicine treatment, are simultaneously given a pediatric spleen and lung clearing formula, mainly inc
Control group:Patients with pneumonia with feipishire syndrome in pneumonia are given symptomatic supportive treatment such as anti-inflammatory, antiviral, and rehydration by Western medicine for 5-7
Sponsors
Sun Simiao Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
1 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Children aged 1 = = 14 years old; 2. Meet the following criteria for Western medicine diagnosis and TCM syndrome differentiation (1) Western medicine diagnosis: According to the "Standards for the Diagnosis and Treatment of Community-Acquired Pneumonia in Children (2019 Edition)" issued by the General Office of the National Health Commission and the State Administration of Traditional Chinese Medicine in 2019. Fever cough and wheezing were the main clinical manifestations. Signs include tachypnea and crackles increased respiratory rate and pulmonary markings in the lungs Bold or flaky shadow on the chest. (2) Traditional Chinese medicine diagnosis: according to the "Guidelines for Common Diagnosis and Treatment of Pediatric Diseases of Traditional Chinese Medicine" and "Clinical Diagnosis and Treatment of Traditional Chinese Medicine No. 2 Some · syndromes" as the standard and the diagnosis of TCM diseases refers to "pneumonia and wheezing" with wheezing coughing and coughing Patients with sputum sputum sound fever and moderate and fine crackles in the lungs are the main manifestations. TCM syndrome differentiation: lung and spleen dampness and heat syndrome Main symptoms: fever cough dull cough wheezing red throat constipation or loose stools. Secondary symptoms: nasal congestion runny nose phlegm cough bad breath poor appetite abdominal distension or abdominal pain yellow urine. Tongue and veins and others: red tongue yellow/white tongue coating pulses or slippery fingerprints purple submandibular nodules; 3. The legal guardian signed the informed consent form and voluntarily participated in this study.
Exclusion criteria
Exclusion criteria: (1) Combined with congenital heart disease bronchopulmonary dysplasia respiratory malformations lung tumors tuberculosis brain dysplasia neurological and muscular diseases chronic liver and kidney diseases hematopoietic diseases etc.; (2) Patients with primary autoimmune deficiency or acute infectious diseases; (3) Children with a history of severe allergies or asthma in the past or allergies to the drugs used in this study; (4) Children with genetic diseases such as Down syndrome trisomy 18 phenylketonuria and juvenile diabetes; (5) Children with severe pneumonia whose condition does not improve after active treatment and whose illness lasts for more than 1 week; (6) Patients who have participated in or are participating in other drug clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Routine blood count of laboratory test results before and after medication;The patient's symptoms are improved, such as the time of fever, the rate of disappearance of cough, and the duration of cough;Signs such as respiratory rate, crackle duration, pharyngeal redness and swelling, and tonsil redness and swelling were found in both groups.;Biochemical results of laboratory examination results before and after medication in patients;Length of hospital stay for the patient; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal symptoms, such as anorexia, bloating, diarrhea, etc;Respiratory relapsed;Symptoms such as cough sputum production fatigue and appetite after discharge from the hospital;The height and weight of the child are measured and the BMI is calculated;Eating behaviour of the children in question; | — |
Countries
China
Contacts
Public ContactXiaohong Gu
Beijing University of Chinese Medicine
Outcome results
None listed